Ogorek Anthony Joseph’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $27K | Sell |
1,154
-112
| -9% | -$2.93K | 0.01% | 252 |
|
|
2026
Q1 | $35K | Sell |
1,266
-8
| -0.6% | -$213 | 0.01% | 206 |
|
|
2025
Q4 | $31K | Buy |
1,274
+289
| +29% | +$7.29K | 0.01% | 210 |
|
|
2025
Q3 | $25K | Sell |
985
-977
| -50% | -$24.1K | 0.01% | 248 |
|
|
2025
Q2 | $47K | Buy |
1,962
+321
| +20% | +$7.49K | 0.01% | 169 |
|
|
2025
Q1 | $41K | Buy |
1,641
+1,508
| +1,134% | +$39.5K | 0.01% | 176 |
|
|
2024
Q4 | $3K | Sell |
133
-323
| -71% | -$8.76K | ﹤0.01% | 267 |
|
|
2024
Q3 | $13K | Buy |
456
+1
| +0.2% | +$29 | ﹤0.01% | 200 |
|
|
2024
Q2 | $12K | Sell |
455
-258
| -36% | -$7.1K | ﹤0.01% | 200 |
|
|
2024
Q1 | $19K | Sell |
713
-203
| -22% | -$5.63K | 0.01% | 169 |
|
|
2023
Q4 | $26K | Sell |
916
-36,812
| -98% | -$1.11M | 0.01% | 153 |
|
|
2023
Q3 | $1.25M | Sell |
37,728
-980
| -3% | -$34.7K | 0.49% | 44 |
|
|
2023
Q2 | $1.42M | Sell |
38,708
-6,063
| -14% | -$236K | 0.54% | 38 |
|
|
2023
Q1 | $1.83M | Sell |
44,771
-1,782
| -4% | -$77K | 0.75% | 36 |
|
|
2022
Q4 | $2.38M | Sell |
46,553
-219
| -0.5% | -$10.5K | 1.04% | 32 |
|
|
2022
Q3 | $2.05M | Buy |
46,772
+1,251
| +3% | +$60.8K | 0.97% | 29 |
|
|
2022
Q2 | $2.39M | Buy |
45,521
+38,343
| +534% | +$1.95M | 1.1% | 28 |
|
|
2022
Q1 | $371K | Buy |
7,178
+177
| +3% | +$9.18K | 0.15% | 50 |
|
|
2021
Q4 | $413K | Buy |
7,001
+13
| +0.2% | +$644 | 0.18% | 44 |
|
|
2021
Q3 | $300K | Buy |
6,988
+14
| +0.2% | +$620 | 0.14% | 44 |
|
|
2021
Q2 | $273K | Buy |
6,974
+2,818
| +68% | +$110K | 0.12% | 45 |
|
|
2021
Q1 | $150K | Buy |
+4,156
| New | +$148K | 0.07% | 51 |
|
|
2020
Q2 | – | Sell |
-211
| Closed | -$6K | – | 204 |
|
|
2020
Q1 | $6K | Hold |
211
| – | – | ﹤0.01% | 151 |
|
|
2019
Q4 | $7K | Hold |
211
| – | – | ﹤0.01% | 162 |
|
|
2019
Q3 | $7K | Hold |
211
| – | – | ﹤0.01% | 128 |
|
|
2019
Q2 | $8K | Hold |
211
| – | – | 0.01% | 118 |
|
|
2019
Q1 | $8K | Hold |
211
| – | – | 0.01% | 112 |
|
|
2018
Q4 | $8K | Hold |
211
| – | – | 0.01% | 104 |
|
|
2018
Q3 | $8K | Buy |
+211
| New | +$8.12K | 0.01% | 113 |
|
Other funds holding PFE
Ogorek Anthony Joseph's PFE Position: Q2 2026 in Review
Ogorek Anthony Joseph reduced its Pfizer (PFE) stake by 8.8% in Q2 2026, selling an estimated $2.93K and leaving 1,154 shares worth $27K. The position accounts for 0.01% of the portfolio, ranked #252.
Ogorek Anthony Joseph first reported a position in PFE in Q3 2018 and has held it in 29 quarters since. The position peaked at $2.39M in Q2 2022. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Ogorek Anthony Joseph held 1,154 shares of Pfizer worth $27K as of Q2 2026.
- Ogorek Anthony Joseph sold 112 Pfizer shares in Q2 2026, an estimated $2.93K.
- Pfizer made up 0.01% of Ogorek Anthony Joseph's portfolio in Q2 2026, its #252 holding.
- Ogorek Anthony Joseph first reported a position in Pfizer in Q3 2018 and has held it in 29 quarters since.
- Ogorek Anthony Joseph's Pfizer position peaked at $2.39M in Q2 2022.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Ogorek Anthony Joseph's 13F filing for Q2 2026, filed 7 Aug 2026.